Australia markets closed

EMVision Medical Devices Ltd (EMV.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
2.1500-0.0500 (-2.27%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 167.61M
Enterprise value 162.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)32.16
Enterprise value/revenue N/A
Enterprise value/EBITDA -70.72

Trading information

Stock price history

Beta (5Y monthly) 1.58
52-week change 331.90%
S&P500 52-week change 322.36%
52-week high 32.7200
52-week low 31.1300
50-day moving average 32.3790
200-day moving average 31.8238

Share statistics

Avg vol (3-month) 363.59k
Avg vol (10-day) 370.35k
Shares outstanding 585.42M
Implied shares outstanding 685.42M
Float 848.91M
% held by insiders 139.54%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -37.17%
Operating margin (ttm)4.75%

Management effectiveness

Return on assets (ttm)-16.10%
Return on equity (ttm)-47.66%

Income statement

Revenue (ttm)8.68M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)34.40%
Gross profit (ttm)N/A
EBITDA -2.69M
Net income avi to common (ttm)-3.22M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.48M
Total cash per share (mrq)0.11
Total debt (mrq)2.97M
Total debt/equity (mrq)52.07%
Current ratio (mrq)1.91
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-3.41M
Levered free cash flow (ttm)-2.06M